As per MRFR analysis, the India Infection Control for the Human Animal Health Market Size was estimated at 382.4 (USD Million) in 2023. The India Infection Control for the Human Animal Health Market Industry is expected to grow from 413.6(USD Million) in 2024 to 1,032 (USD Million) by 2035. The India Infection Control for the Human Animal Health Market CAGR (growth rate) is expected to be around 8.668% during the forecast period (2025 - 2035).
Key India Infection Control for the Human Animal Health Market Trends Highlighted
The India Infection Control for the Human Animal Health Market is witnessing significant market trends influenced by various factors. One of the key market drivers is the increasing awareness about zoonotic diseases, which has prompted both the government and private sectors to prioritize infection control measures. With a growing population and expanding urbanization, the risks associated with infectious diseases have surged, driving demand for effective infection control solutions.
Additionally, the rise in livestock farming and the rapid growth of the veterinary pharmaceutical industry in India further contribute to the need for enhanced infection control protocols.Opportunities to be explored include the development of innovative disinfection technologies and the implementation of robust health management programs. These initiatives aim to improve biosecurity in both human and animal health environments.
Furthermore, the government's push for livestock vaccination drives and the establishment of disease surveillance systems present avenues for market players to expand their offerings and services within this domain. Trends in recent times indicate a shift towards the adoption of digital technologies in infection management, enabling real-time monitoring and data analytics for better decision-making.
The pandemic has accelerated the need for more stringent hygiene protocols within various sectors, demonstrating a heightened focus on comprehensive infection control strategies.Organizations are increasingly investing in training programs for health professionals, ensuring that they are well-equipped with the latest knowledge and practices in infection control for both human and animal health in India. Overall, these trends highlight a proactive approach toward enhancing public health infrastructure, thereby significantly impacting the India Infection Control for the Human Animal Health Market.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
India Infection Control for the Human Animal Health Market Drivers
Rising Awareness About Infectious Diseases
The India Infection Control for the Human Animal Health Market Industry has grown tremendously as a result of the country's increased awareness of infectious illnesses, particularly zoonotic diseases that may spread from animals to people. With 69% of infectious illnesses that harm people coming from animals, the Indian government has observed an increase in zoonotic disease surveillance.
Initiatives to manage these illnesses have been started by groups like the Indian Council of Agricultural Research, which has a direct effect on public health. Effective infection control methods, including vaccinations and sanitization procedures, are essential, which will accelerate market expansion.
Government Initiatives and Funding
Government initiatives aimed at improving animal health and control measures have catalyzed the growth in the India Infection Control for the Human Animal Health Market Industry. The Indian government's investment in sectors like Research and Development for vaccines and other medical interventions has increased significantly, with allocated funds amounting to over USD 300 million in recent years.
Initiatives like the National Animal Disease Control Programme aim to vaccinate over 500 million livestock, which not only helps in controlling diseases but also fosters competitiveness in the market.This strategy reflects a strong commitment to enhancing national health standards.
Expansion of the Pharmaceutical and Biotechnology Sector
The rapid expansion of the pharmaceutical and biotechnology industry in India is another significant driver of the India Infection Control for the Human Animal Health Market Industry. India ranks as the third-largest pharmaceutical market globally in terms of volume, and this growth has led to innovative research in vaccine development and disease management solutions.
Established firms such as Serum Institute of India and Bharat Biotech are key players, investing significantly in R&D to create cost-effective vaccines.Furthermore, India's capability to produce large volumes of veterinary vaccines positions it as a leader in infection control measures for both human and animal health, further enhancing market prospects.
India Infection Control for the Human Animal Health Market Segment Insights
Infection Control for the Human Animal Health Market Product Insights
The India Infection Control for the Human Animal Health Market shows significant potential in its Product segment, focusing notably on Disinfection Products, Personal Protective Equipment (PPE), and Sterilization Equipment. Considering the heightened awareness surrounding health and hygiene, particularly in the wake of recent health crises, these products have become essential for both human and animal care sectors. Disinfection Products are paramount in preventing the spread of pathogens, thereby playing a critical role in healthcare settings and among veterinary services, ensuring that facilities maintain rigorous sanitation standards.
The demand for effective Personal Protective Equipment has surged, driven by increased usage in hospitals, laboratories, and animal health institutions, where the risk of exposure to infectious agents is considerable. PPE safeguards healthcare workers and veterinary staff, contributing significantly to the overall efficacy of infection control strategies. Moreover, Sterilization Equipment is crucial in eliminating microorganisms from surgical tools and environments, thereby minimizing infection risks.
The emphasis on stringent sterilization protocols within both human and animal healthcare reinforces the importance of this segment, as it ensures compliance with health regulations and enhances patient safety.As India's healthcare landscape continues to evolvefueled by growing awareness, shifts in consumer preferences, and regulatory initiatives Product segment is expected to play a pivotal role in shaping the India Infection Control for the Human Animal Health Market. With a rising population and increased focus on improving healthcare standards, the India Infection Control for the Human Animal Health Market segmentation demonstrates robust growth potential across all identified areas, contributing to an overall expansion of the market landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Infection Control for the Human Animal Health Market Infection Type Insights
The India Infection Control for the Human Animal Health Market showcases a diverse array of infection types, which are crucial for ensuring public health and animal welfare. Within this market, the segmentation includes Viral, Bacterial, Parasitic, and Fungal Infections, each presenting unique challenges and growth opportunities. Viral infections, often associated with rapid transmission and severe health implications, play a significant role in heightening the demand for effective preventive measures.
Bacterial infections, commonly leading to zoonotic diseases, highlight the necessity for robust infection control practices in both human and animal health sectors in India.The increasing instances of parasitic infections, particularly in livestock, also emphasize the market's importance as they pose substantial threats to food security and animal productivity.
Meanwhile, fungal infections are gaining attention due to their rising prevalence and potential for outbreaks, prompting the need for continuous research and development. Collectively, these infection types shape the India Infection Control for the Human Animal Health Market landscape, driving innovations and investments in safety protocols, diagnostics, and treatment solutions aimed at mitigating their impact.
Infection Control for the Human Animal Health Market End User Insights
The India Infection Control for the Human Animal Health Market focuses significantly on the End User segment, which is divided between Human Healthcare Facilities and Animal Healthcare Facilities. Human Healthcare Facilities play a crucial role in the prevention and management of infections, driven by the increasing burden of healthcare-associated infections and rising patient expectations for safety protocols.
This segment utilizes advanced infection control solutions to maintain hygiene standards and protect patients from infectious diseases. Meanwhile, Animal Healthcare Facilities emphasize biosecurity and sanitation to mitigate the risk of infections in livestock and companion animals, a necessity given the growing concerns over zoonotic diseases.The rising demand for veterinary services and products reflects a growing awareness within the agriculture and pet care sectors about the importance of infection control.
Overall, the significance of these End User categories highlights the increasing investments in Research and Development aimed at introducing new products and protocols to ensure effective infection management across both human and animal health domains in India.
India Infection Control for the Human Animal Health Market Key Players and Competitive Insights
The India Infection Control for the Human Animal Health Market is characterized by a complex interplay of various players striving to establish a strong foothold amid rising health concerns linked to infectious diseases. This market has witnessed significant growth owing to increasing awareness around animal health and the essential role veterinarians play in disease prevention and management. Companies in this space are continually innovating to offer effective solutions that prevent and control infections, thus ensuring optimal health in both domestic and livestock animals.
The competitive landscape features a mix of well-established multinational corporations and emerging local companies, each bringing a unique set of products and services to address the diverse needs of animal health care.Elanco has made a notable mark in the India Infection Control for the Human Animal Health Market with its commitment to advancing animal health through innovative solutions. The company has consistently demonstrated strengths in its research and development capabilities, leading to a robust portfolio of products that cater to a variety of animal species.
Elanco's strategic focus on enhancing its product offerings and expanding its market reach in India has enabled it to establish strong relationships with veterinary professionals and animal health stakeholders. Furthermore, its dedication to improving animal welfare and sustainability has resonated well in the Indian market, allowing Elanco to effectively position itself as a trusted leader in infection control solutions for both companion animals and livestock.Vetoquinol, another key player in the India Infection Control for the Human Animal Health Market, has garnered attention for its comprehensive range of veterinary pharmaceuticals and health products designed to combat infections effectively.
The company’s product portfolio includes vital medications that focus on preventing and treating various infectious diseases in animals, along with nutritional supplements that support overall health. Vetoquinol's strengths lie in its commitment to innovation and quality, which have enabled it to penetrate the Indian market successfully.
Keeping customer needs at the forefront, Vetoquinol has forged partnerships and actively sought mergers and acquisitions to enhance its capabilities and expand its product offerings in the region. This strategic approach has contributed to its solid market presence, positioning Vetoquinol as a significant contributor to infection control efforts within India's animal health landscape.
Key Companies in the India Infection Control for the Human Animal Health Market Include
India Infection Control for the Human Animal Health Market Industry Developments
In recent developments within the India Infection Control for the Human Animal Health Market, significant activities have been observed. In September 2023, Zydus Cadila and Indian Immunologicals expanded their product lines to include advanced vaccines aimed at improving infection control for livestock. Furthermore, Merck Animal Health has been actively collaborating with local farms to enhance biosecurity measures through educational programs and products.
Glenmark Pharmaceuticals recently announced a strategic partnership with local veterinary clinics to deploy rapid diagnostic tests focusing on zoonotic infections. Moreover, in February 2023, Elanco completed an acquisition of a smaller veterinary health firm specializing in topical infection treatments, reflecting its growth strategy in India’s expanding market. In a similar vein, Ceva Santé Animale has launched a new range of antifungal and antibacterial products aimed specifically at ensuring the health of companion animals.
The Indian infection control market for human-animal health continues to grow, driven by increased awareness of zoonotic diseases and the need for better disease management, with the overall market size expected to expand significantly through 2025. Major players are investing in local Research and Development to cater to the diverse needs in this sector.
India Infection Control for the Human Animal Health Market Segmentation Insights
Infection Control for the Human Animal Health Market Product Outlook
Infection Control for the Human Animal Health Market Infection Type Outlook
Infection Control for the Human Animal Health Market End User Outlook
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 382.4(USD Million) |
| MARKET SIZE 2024 | 413.6(USD Million) |
| MARKET SIZE 2035 | 1032.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.668% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Elanco, Vetoquinol, Glenmark Pharmaceuticals, Indoco Remedies, Heska Corporation, Merck Animal Health, Zydus Cadila, Indian Immunologicals, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Dechra Pharmaceuticals, Phibro Animal Health, Zoetis |
| SEGMENTS COVERED | Product, Infection Type, End User |
| KEY MARKET OPPORTUNITIES | Increased demand for sanitization products, Growing prevalence of zoonotic diseases, Expansion of healthcare infrastructure, Rising awareness of infection prevention, Government support for animal health initiatives |
| KEY MARKET DYNAMICS | Growing zoonotic disease prevalence, Increasing regulatory standards, Rising awareness of infection control, Advancements in healthcare technologies, Expansion of veterinary healthcare services |
| COUNTRIES COVERED | India |
Frequently Asked Questions (FAQ) :
The India Infection Control for the Human Animal Health Market is expected to be valued at 413.6 million USD in 2024.
By 2035, the market is anticipated to reach a valuation of 1032.0 million USD.
The market is projected to grow at a CAGR of 8.668% during the period from 2025 to 2035.
The Personal Protective Equipment (PPE) segment is expected to dominate the market, valued at 150.0 million USD in 2024.
The market value for Disinfection Products is expected to reach 300.0 million USD by 2035.
Major players in the market include Elanco, Vetoquinol, Glenmark Pharmaceuticals, and Merck Animal Health among others.
Sterilization Equipment is expected to have a market size of 143.6 million USD in 2024.
Emerging trends in infection control and increased awareness of animal health represent key growth opportunities in the market.
The Personal Protective Equipment segment is forecasted to grow to 400.0 million USD by 2035.
Key competitors face challenges related to innovation and keeping up with regulatory standards in an evolving market landscape.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
